References
- Leber MF, Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol. 2009;34(4):881–95. doi:https://doi.org/10.3892/ijo_00000214
- Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc Health Risk Manag. 2006;2(3):213–9. doi:https://doi.org/10.2147/vhrm.2006.2.3.213
- Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1(1):27–30. doi:https://doi.org/10.1038/nm0195-27
- Lee CZ, Xu B, Hashimoto T, McCulloch CE, Yang G-Y, Young WL. Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke. 2004;35(7):1715–9. doi:https://doi.org/10.1161/01.STR.0000129334.05181.b6
- Könnecke H, Bechmann I. The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol. 2013;2013:914104. doi:https://doi.org/10.1155/2013/914104
- Hajighasemi F, Gheini MH. Lipopolysaccharide effect on vascular endothelial factor and matrix metalloproteinases in leukemic cell lines in vitro. Iran J Cancer Preven. 2015;8(3):9–14. doi:https://doi.org/10.17795/ijcp2327
- Pearson JR, Regad T. Targeting cellular pathways in glioblastoma multiforme. Signal Transduct Target Ther. 2017;2:17040. doi:https://doi.org/10.1038/sigtrans.2017.40
- Wirsching H-G, Weller M. The role of molecular diagnostics in the management of patients with gliomas. Curr Treat Options Oncol. 2016;17(10):51. doi:https://doi.org/10.1007/s11864-016-0430-4
- Ostrom QT, Gittleman H, Stetson L, Virk SM, Barnholtz-Sloan JS. Epidemiology of gliomas. Cancer Treat Res. 2015;163:1–14. doi:https://doi.org/10.1007/978-3-319-12048-5_1
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96. doi:https://doi.org/10.1056/NEJMoa043330
- Li X-Q, Ouyang Z-G, Zhang S-H, Liu H, Shang Y, Li Y, Zhen Y-S. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin. Cancer Biol Ther. 2014;15(4):398–408. doi:https://doi.org/10.4161/cbt.27626
- Elhag R, Mazzio EA, Soliman KF. The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines. Anticancer Res. 2015;35(3):1263–9.
- Atif F, Patel NR, Yousuf S, Stein DG. The synergistic effect of combination progesterone and temozolomide on human glioblastoma cells. PloS One. 2015;10(6):e0131441. doi:https://doi.org/10.1371/journal.pone.0131441
- Mirabdaly S, Komi DEA, Shakiba Y, Moini A, Kiani A. Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties. Mol Biol Rep. 2020;47(2):1187. doi:https://doi.org/10.1007/s11033-019-05219-2
- Zhang X, Ni Q, Wang Y, Fan H-w, Li Y. Synergistic anticancer effects of formononetin and temozolomide on glioma C6 cells. Biol Pharm Bull. 2018;41(8):1194. doi:https://doi.org/10.1248/bpb.b18-00002
- Hu H, Hao L, Yan B, Li X, Zhu Y, Yao J, Wang G, Jiang Q. Gefitinib inhibits retina angiogenesis by affecting VEGF signaling pathway. Biomed Pharmacother. 2018;102:115–9. doi:https://doi.org/10.1016/j.biopha.2018.02.110
- Rich JN, Reardon DA, Peery T, Dowell JM, Quinn JA, Penne KL, Wikstrand CJ, Van Duyn LB, Dancey JE, McLendon RE, et al. Phase II trial of gefitinib in recurrent glioblastoma. J Clin Oncol. 2004;22(1):133–42. doi:https://doi.org/10.1200/JCO.2004.08.110
- Lee KE, Hahm E, Bae S, Kang JS, Lee WJ. The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells . Oncol Lett. 2017;14(1):276–82. doi:https://doi.org/10.3892/ol.2017.6109
- Macha MA, Rachagani S, Gupta S, Pai P, Ponnusamy MP, Batra SK, Jain M. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Lett. 2013;341(2):166–77. doi:https://doi.org/10.1016/j.canlet.2013.07.037
- Le Calvé B, Rynkowski M, Le Mercier M, Bruyère C, Lonez C, Gras T, Haibe-Kains B, Bontempi G, Decaestecker C, Ruysschaert J-M, et al. Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia. 2010;12(9):727–39. doi:https://doi.org/10.1593/neo.10526
- Karami A, Hamzeloo-Moghadam M, Yami A, Barzegar M, Mashati P, Gharehbaghian A. Antiproliferative effect of gaillardin from inula oculus-christi in Human Leukemic Cells. Nutr Cancer. 2020;72(6):1043. doi:https://doi.org/10.1080/01635581.2019.1665188
- Pazhouhi M, Sariri R, Khazaei MR, Moradi MT, Khazaei M. Synergistic effect of temozolomide and thymoquinone on human glioblastoma multiforme cell line (U87MG). J Cancer Res Ther. 2018;14(5):1023–8. doi:https://doi.org/10.4103/0973-1482.187241
- Cantarella G, Risuglia N, Dell’eva R, Lempereur L, Albini A, Pennisi G, Scoto GM, Noonan DN, Bernardini R. TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells. Br J Cancer. 2006;94(10):1428–35. doi:https://doi.org/10.1038/sj.bjc.6603092
- Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 1984;307(5951):521–7. doi:https://doi.org/10.1038/307521a0
- Westphal M, Maire CL, Lamszus K. EGFR as a target for glioblastoma treatment: an unfulfilled promise. CNS Drugs. 2017;31(9):723–35. doi:https://doi.org/10.1007/s40263-017-0456-6
- Carrasco-García E, Saceda M, Martínez-Lacaci I. Role of receptor tyrosine kinases and their ligands in glioblastoma. Cells. 2014;3(2):199–235. doi:https://doi.org/10.3390/cells3020199
- Bhullar KS, Lagarón NO, McGowan EM, Parmar I, Jha A, Hubbard BP, Rupasinghe HPV. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer. 2018;17(1):1–20. doi:https://doi.org/10.1186/s12943-018-0804-2
- Kurzen H, Schmitt S, Näher H, Möhler T. Inhibition of angiogenesis by non-toxic doses of temozolomide. Anticancer Drugs. 2003;14(7):515–22. doi:https://doi.org/10.1097/00001813-200308000-00003
- Mathieu V, De Nève N, Le Mercier M, Dewelle J, Gaussin J-F, Dehoux M, Kiss R, Lefranc F. Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. Neoplasia. 2008;10(12):1383–92. doi:https://doi.org/10.1593/neo.08928
- Steiner H-H, Karcher S, Mueller MM, Nalbantis E, Kunze S, Herold-Mende C. Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels. J Neurooncol. 2004;66(1-2):129–38. doi:https://doi.org/10.1023/b:neon.0000013495.08168.8f
- Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol. 2005;7(2):134–53. doi:https://doi.org/10.1215/S1152851704001115
- Raithatha SA, Muzik H, Muzik H, Rewcastle NB, Johnston RN, Edwards DR, Forsyth PA. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro Oncol. 2000;2(3):145–50. doi:https://doi.org/10.1093/neuonc/2.3.145
- Wang M, Wang T, Liu S, Yoshida D, Teramoto A. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol. 2003;20(2):65–72. doi:https://doi.org/10.1007/BF02483449
- Parker JJ, Dionne KR, Massarwa R, Klaassen M, Foreman NK, Niswander L, Canoll P, Kleinschmidt-Demasters BK, Waziri A. Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma. Neuro Oncol. 2013;15(8):1048–57. doi:https://doi.org/10.1093/neuonc/not053